List of brands containing nabumetone
This page contains list of brands of authorized pharmaceutical specialties of the active principle nabumetone in the countries listed below:
[ Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]
Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.
Nabumetone belongs to a group of drugs called non-steroidal anti-inflammatory drugs (NSAIDs) with high anti-inflammatory activity and analgesic and antipyretic properties.
This drug is indicated for the treatment of inflammatory disorders, such as osteoarthritis and rheumatoid arthritis.
Medizzine recommends consulting your doctor if you are unsure (or you do not know) why you have been given nabumetone.
Other ingredients of available commercial presentations:
Tablets: Besides the active principle, other ingredients are croscarmellose sodium, povidone, sodium lauryl sulfate, dried peppermint essence, vanilla essence, magnesium stearate, microcrystalline cellulose, and sodium saccharin.
Oral suspension; In addition to 100 mg/ml active ingredient, the oral suspension contains methylcellulose, xanthan gum, sodium benzoate, ammonium dihydrogen glycyrrhizate, sorbitol, glycerol, hydrochloric acid, flavorings, and pùrified water.
Warning:
The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.
The oral solution contains sorbitol. If your doctor has told you that you have an intolerance to sugars, contact him before taking it.
The oral suspension contains sorbitol. If your doctor has told you that you have an intolerance to sugars, contact him before taking it.
Do not use nabumetone
If you are allergic (hypersensitive) to nabumetone, to acetylsalicylic acid (aspirin and others) and to any other nonsteroidal anti-inflammatory drug or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.
Allergy symptoms may include:
- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).
Nor you should take this medicine:
- If you have or have had an active peptic ulcer
- If you have or have had a severe liver disease (cirrhosis)
- If you have had an ulcer or bleeding stomach or duodenum or suffered a perforation of the digestive tract
- If you have severe heart failure
- If you are in the third trimester of pregnancy.
Take special care with nabumetone
- If you have or have had a severe kidney disease
- If you have or have had a liver disease
- If you have or have had vision problems
- If you are taking other medicines of the same type as nabumetone (anti-inflammatory nonsteroidal)
It is important that you use the lowest dose that relieves / control pain. Nabumetone should not be taken longer than necessary to control symptoms.
Gastrointestinal precautions:
Take special care:
- If you have had or develop an ulcer, bleeding or perforation of the stomach or duodenum, which can be manifested by an intense or persistent abdominal pain and / or black stools, or even without previous warning symptoms .
- This risk is higher when high doses and prolonged treatment are used, in patients with a history of peptic ulcer disease, and in the elderly. In these cases, your doctor will consider the possibility of associating a protective medicine stomach .
Tell your doctor:
- If simultaneously you are taking medications that alter the blood clotting such as corticosteroids, oral anticoagulants or antiplatelet agents acetylsalicylic type acid. You should also tell the use of other drugs that may increase the risk of bleeding such as corticosteroids and antidepressants selective inhibitors of serotonin reuptake
- If you have Crohn's disease or ulcerative colitis since the drugs from the type of nabumetone may worsen these conditions.
Cardiovascular precautions:
Medications such as nabumetone may be associated with a small increased risk of suffering a brain or heart attack (stroke, myocardial infarction). This risk is more likely to occur when high doses and prolonged treatment are used. Do not exceed the dose nor the recommended duration of the treatment.
If you have heart problems, history of stroke, or think you might be at risk to suffer these pathologies (eg, if you have high blood pressure, diabetes, have increased cholesterol or you are a smoker) should consult this treatment with your doctor or pharmacist.
In addition, these drugs can cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Consult your doctor, if any of the above circumstances had ever happened.
Remember that your doctor has prescribed this medicine only for you. Never give it to someone else.
If in doubt, consult your doctor.
Taking other medicines
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal products or drugs obtained without a prescription.
Especially:
- Other NSAIDs (painkillers such as aspirin, naproxen or ibuprofen),
- Corticosteroids (drugs that reduce inflammation, such as hydrocortisone),
- Medicines used to treat depression, including selective serotonin reuptake inhibitors (SSRIs),
- Anti-coagulants (blood thinners such as warfarin),
- Anticonvulsants (treatment for epilepsy),
- Antiplatelet agents (medicines that help prevent the formation of blood clots),
- Oral antidiabetic agents (sulphonylurea such as glibenclamide),
- Sulphonamides (used as anti-bacterial agents),
- Cardiac glycosides (for heart conditions, such as digoxin),
- Lithium (for mental illness, such as bipolar disorders),
- Methotrexate (for rheumatoid arthritis and some cancer),
- Diuretics (water pills),
- Antihypertensive drugs,
- Mifepristone (for abortion),
- Quinolones (a type of antibiotic),
- Cyclosporine and tacrolimus (for preventing organ rejection after transplants),
- Zidovudine (to treat HIV).
However, despite it, may be appropriate for you to take nabumetone and your doctor may decide that it is suitable for you
Use with food and beverages
Nabumetone should be taken with or after food
Special physiological situations
Pregnancy and lactation:
Always consult your doctor or pharmacist before taking any medicine during pregnancy or breastfeeding.
As nabumetone has been associated with an increased risk of congenital abnormalities and abortions, its administration is not recommended during the first and second trimesters of pregnancy unless it is considered absolutely necessary. In these cases, the dose and duration will be limited to a minimum.
The administration of nabumetone is contraindicated during the third trimester of pregnancy.
For patients of childbearing age should be aware that the type of drug as nabumetone has been associated with a decreased ability to conceive.
the use of nabumetone during lactation is not recommended unless, in the opinion of the physician, the potential benefit to the mother justifies the potential risk to the infant.
Children
It is not recommended for use in children.
Driving and using machines
Patients who experience dizziness or other central nervous system disorders, should not drive cars, neither operating machinery and should avoid situations that require a special alert situation.
Consult your doctor or pharmacist before taking any medicine.
Follow carefully instructions of use of nabumetone provided by your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given in this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.
Adults: The usual dosage is 1 g per day orally. The tablets may be taken with or without food. In those cases where the physician deems it appropriate, the dose may be increased up to 1500 or 2000 mg, which may be taken as a single dose or divided into two doses. Do not exceed the dose of 2000 mg per day.
Children This medicine is not recommended for children
Elderly: Normally, no dose adjustment is required in the elderly. In all the cases, always follow the advice of your doctor.
Renal impairment: generally it is not necessary to adjust the dose in patients with kidney failure.
Nabumetone tablets must be dissolved in a little water before administration.
Your doctor will indicate the duration of treatment with nabumetone. Do not stop treatment earlier.
If you think the effect of the medicine is too strong or too weak, consult your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
While you take nabumetone
▲If a doctor prescribes another medicine, tell you are taking nabumetone.
Check with your doctor regularly developments of disorder that motivates the use of nabumetone. Maybe there is some reason that prevented you properly receive the indicated doses and induce your doctor to erroneous conclusions about treatment.
Do not restart treatment with nabumetone at your own risk without first talking to your doctor, nor encourage its use by another person, even if have the same symptoms you have. Nor is it advisable to interrupt or reduce the dose without considering the opinion of your doctor.
If you feel unwell during treatment with nabumetone, immediately consult your doctor.
If you take more than you should:
In the case of overdose or accidental ingestion, consult the Toxicology Information Service in your country.
If the amount ingested is important, immediately consult your doctor or pharmacist or go to the emergency room of the nearest hospital. Take the pack and the rest of unconsumed medicine.
If you forget to take nabumetone
Do not take a double dose to make up for missed doses.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Side Effects of nabumetone
▲Like all medicines, nabumetone can cause side effects although not everybody gets them.
The frequency of side effects is classified into:
Very common: affect 1 out of 1-10 patients
Common: affect 1 out of 10-100 patients
Uncommon: affect 1 out of 100-1.000 patients
Rare: affect 1 out of 1.000-10.000 patients
Very Rare: affect less than 1 in 10,000 patients
Incidence not known: Can not be established the true incidence from the available data
The most common side effects that occur with drugs such as nabumetone are gastrointestinal: peptic ulcers, gastrointestinal bleeding, perforations (in some cases fatal) , especially in the elderly. Also, have also been observed nausea, vómiting, diarrhea, flatulence, constipation, heartburn, abdominal pain, blood in stool, canker sores, worsening of ulcerative colitis and Crohn 's disease . Less frequently have been observed the occurrence of gastritis.
Cardiovascular side effects:
Medications such as nabumetone may be associated especially with a small increased risk of cerebral or heart attack (myocardial infarction, stroke). It has also been observed edema (fluid retention).
Cutaneous side effects:
Medications such as nabumetone may be associated very rarely to very serious bullous reactions such as Stevens-Johnson syndrome and necrolysis epidermal toxic. It has also been observed rash.
Liver side effects:
Medications such as nabumetone may be associated with liver disorders that cause
yellowing of skin and eyes (jaundice) , sometimes with high fever or swelling and sensitivity of the upper abdomen . If yellowish discoloration of skin or eyes occurs, stop treatment and tell your doctor IMMEDIATELY.
Other adverse effects:
Headache, vertigo, fatigue, drowsiness, insomnia, blurred vision.
This list does not include all adverse reactions associated with the use of nabumetone, both well established as those that are under consideration or confirmation. In case you feel unwell, should immediately consult with the doctor who prescribed this medicine.
If you notice any side effects not listed in this website or in the leaflet accompanying the package, ask your doctor or pharmacist.
If any of the side effects gets serious, tell your doctor or pharmacist.
List of brands containing nabumetone
▲This page contains list of brands of authorized pharmaceutical specialties of the active principle nabumetone in the countries listed below:
[ Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]
Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.
Warning:
With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.
Australia: ▲
N/A
Brazil: ▲
N/A
Canada: ▲
APO-NABUMETONE 500 mg, 60 & 100 tablets
MYLAN-NABUMETONE 500 mg, 100 tablets
NABUMETONE SANIS 500 mg, 100 tablets
TEVA-NABUMETONE 500 mg, 60 % 100 tablets
TEVA-NABUMETONE 750 mg, 60 & 100 tablets
France: ▲
NABUCOX 500 mg, 28 tablets
NABUCOX 1000 mg, 14 & 28 dispersible tablets
Germany: ▲
ARTHOXAN 100 mg/ml, 300 ml oral suspension
ARTHOXAN 1000 mg, 20 tablets
RELIFEX 500 mg, 20-50-100 tablets
India: ▲
NABUFLAM 500 mg, tablets
NILTIS 500 mg, tablets
NILTIS 750 mg, tablets
Italy: ▲
ARTAXAN 1000 mg, 30 tablets
ARTAXAN 1000 mg, 30 sachets granules for oral suspension
NABUSER 1000 mg, 30 tablets
NABUSER 1000 mg, 30 sachets granules for oral suspension
RELIFEX 1000 mg, 30 tablets
Japan: ▲
RELIFEN 400 mg, tablets
Mexico: ▲
NAFLAM 500 mg, 20, 30 & 50 tablets
RELIFEX 500 mg, 15 & 30 tablets
Pakistan: ▲
NILTISL 500 MG, tablets
RELIFEX 500 mg, tablets
Spain: ▲
LISTRAN 1000 mg, 20 dispersible tablets
RELIF 1000 mg, 20 dispersible tablets
Turkey: ▲
N/A
United Kingdom: ▲
NABUMETONE AAH PHARMA 500 mg, 56 tablets
NABUMETONE ACTAVIS 500 mg, 56 tablets
NABUMETONE ALLIANCE HEALTHCARE 500 mg, 56 tablets
NABUMETONE GENERICS 500 mg, 56 tablets
NABUMETONE KENT PHARMA 500 mg, 56 tablets
NABUMETONE MEDA PHARMA 500 mg, 56 tablets
RELIFEX 500 mg, 56 tablets
RELIFEX 100mg/ml, 300 ml oral suspension
U.S.A. and Puerto Rico: ▲
NABUMETONE EON LABS 500 mg, 100 tablets
NABUMETONE EON LABS 750 mg, 100 tablets
NABUMETONE PAR PHARMA 500 mg, 100 tablets
NABUMETONE PAR PHARMA 750 mg, 100 tablets
NABUMETONE ALTURA PHARMA 500 mg, 30, 60, 90 & 100 tablets
NABUMETONE ALTURA PHARMA 750 mg, 30, 60, 90 & 100 tablets
NABUMETONE BLENHEIM PHARMACAL 500 mg, 20, 30, 40 & 60 tablets
NABUMETONE MAJOR 500 mg, 100 tablets
NABUMETONE MAJOR 750 mg, 100 tablets
NABUMETONE REMEDYREPACK 500 mg, 30 tablets
NABUMETONE STAT RX USA LLC 750 mg, 20-90 tablets
NABUMETONE AMERICAN HEALTH PACK 500 mg, 100 tablets
NABUMETONE BRYANT RANCH PREPACK 500 mg, 14-100 tablets
NABUMETONE BRYANT RANCH PREPACK 750 mg, 14-100 tablets
NABUMETONE GLENMARK 500 mg, 100 tablets
NABUMETONE GLENMARK 750 mg, 100 tablets
NABUMETONE LAKE ERIE 500 mg, 30 tablets
NABUMETONE LAKE ERIE 750 mg, 30 & 60 tablets
NABUMETONE MYLAN 500 mg, 60 & 100 tablets
NABUMETONE MYLAN 750 mg, 60 & 100 tablets
NABUMETONE NCS HEALTHCARE OF KY 500 mg, 30 tablets
NABUMETONE NCS HEALTHCARE OF KY 750 mg, 30 tablets
NABUMETONE PHYSICIANS TOTAL CARE 500 mg, 20, 30, 60 & 100 tablets
NABUMETONE PHYSICIANS TOTAL CARE 750 mg, 20, 30, 60 & 100 tablets
NABUMETONE REBEL 500 mg, 14-60 tablets
NABUMETONE REBEL 750 mg, 14-90 tablets
NABUMETONE TEVA 500 mg, 100 tablets
NABUMETONE TEVA 750 mg, 90 y 100 tablets
NABUMETONE UDL 500 mg, 100 tablets
NABUMETONE WATSON 500 mg, 100 tablets
NABUMETONE WATSON 750 mg, 100 tablets
RELAFEN 500 mg, 100 tablets
RELAFEN 750 mg, 100 tablets
Page updated: December 11, 2010.